Outcomes of Chronic Myeloid Leukemia Patients With Early Molecular Response at 3 and 6 Months: A Comparative Analysis of Generic Imatinib and Glivec

Autor: Eskazan, Ahmet Emre, Sadri, Sevil, Keskin, Dilek, Ayer, Mesut, Kantarcioglu, Bulent, Demirel, Naciye, Aydin, Demet, Aydinli, Fuat, Yokus, Osman, Ozunal, Isil Erdogan, Berk, Selin, Yalniz, Fevzi Firat, Elverdi, Tugrul, Salihoglu, Ayse, Ar, Muhlis Cem, Ongoren, Seniz, Baslar, Zafer, Aydin, Yildiz, Tuzuner, Nukhet, Ozbek, Ugur, Soysal, Teoman
Zdroj: In Clinical Lymphoma Myeloma and Leukemia December 2017 17(12):804-811
Databáze: ScienceDirect
Externí odkaz: